Cargando…

Glucagon-Like Peptide-1 Triggers Protective Pathways in Pancreatic Beta-Cells Exposed to Glycated Serum

Advanced glycation end products (AGEs) might play a pathophysiological role in the development of diabetes and its complications. AGEs negatively affect pancreatic beta-cell function and the expression of transcriptional factors regulating insulin gene. Glucagon-like peptide-1 (GLP-1), an incretin h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Puddu, Alessandra, Sanguineti, Roberta, Durante, Arianna, Nencioni, Alessio, Mach, François, Montecucco, Fabrizio, Viviani, Giorgio L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3657444/ https://www.ncbi.nlm.nih.gov/pubmed/23737644 http://dx.doi.org/10.1155/2013/317120

Ejemplares similares

An Emerging Role of Glucagon-Like Peptide-1 in Preventing Advanced-Glycation-End-Product-Mediated Damages in Diabetes
por: Puddu, Alessandra, et al.
Publicado: (2013)

Glucagon-Like Peptide-1 Secreting Cell Function as well as Production of Inflammatory Reactive Oxygen Species Is Differently Regulated by Glycated Serum and High Levels of Glucose
por: Puddu, Alessandra, et al.
Publicado: (2014)

Effects of High Glucose Levels and Glycated Serum on GIP Responsiveness in the Pancreatic Beta Cell Line HIT-T15
por: Puddu, Alessandra, et al.
Publicado: (2015)

Advanced Glycation End Products Play Adverse Proinflammatory Activities in Osteoporosis
por: Sanguineti, Roberta, et al.
Publicado: (2014)

Retinal Pigment Epithelial Cells Express a Functional Receptor for Glucagon-Like Peptide-1 (GLP-1)
por: Puddu, Alessandra, et al.
Publicado: (2013)

Update on the Protective Molecular Pathways Improving Pancreatic Beta-Cell Dysfunction
por: Puddu, Alessandra, et al.
Publicado: (2013)

Vascular endothelial growth factor-C secretion is increased by advanced glycation end-products: possible implication in ocular neovascularization
por: Puddu, Alessandra, et al.
Publicado: (2012)

Evidence for the Gut Microbiota Short-Chain Fatty Acids as Key Pathophysiological Molecules Improving Diabetes
por: Puddu, Alessandra, et al.
Publicado: (2014)

Advanced Glycation End-Products and Hyperglycemia Increase Angiopoietin-2 Production by Impairing Angiopoietin-1-Tie-2 System
por: Puddu, Alessandra, et al.
Publicado: (2019)

Role of Mitogen-Activated Protein Kinase Pathways in Multifactorial Adverse Cardiac Remodeling Associated with Metabolic Syndrome
por: Asrih, Mohamed, et al.
Publicado: (2013)

Update on the Pathophysiological Role of Intracellular Signaling Pathways in Atherosclerotic Plaques and Ischemic Myocardium
por: Montecucco, Fabrizio, et al.
Publicado: (2012)

miR-126 Mimic Counteracts the Increased Secretion of VEGF-A Induced by High Glucose in ARPE-19 Cells
por: Sanguineti, Roberta, et al.
Publicado: (2021)

Caveolin-1 Down-Regulation Reduces VEGF-A Secretion Induced by IGF-1 in ARPE-19 Cells
por: Puddu, Alessandra, et al.
Publicado: (2021)

Caveolin-1 and Atherosclerosis: Regulation of LDLs Fate in Endothelial Cells
por: Puddu, Alessandra, et al.
Publicado: (2023)

Glucagon-like peptide receptor agonists attenuate advanced glycation end products-induced inflammation in rat mesangial cells
por: Chang, Jui-Ting, et al.
Publicado: (2017)

Computational Peptide Design Cotargeting Glucagon and Glucagon-like Peptide-1 Receptors
por: Vishnoi, Shubham, et al.
Publicado: (2023)

Insulin receptor signaling and glucagon-like peptide 1 effects on pancreatic beta cells
por: Caporarello, Nunzia, et al.
Publicado: (2017)

The Interplay of Glucagon-Like Peptide-1 Receptor Trafficking and Signalling in Pancreatic Beta Cells
por: Marzook, Amaara, et al.
Publicado: (2021)

Correction: Glucagon-like peptide receptor agonists attenuate advanced glycation end products-induced inflammation in rat mesangial cells
por: Chang, Jui-Ting, et al.
Publicado: (2023)

Stability of glucagon-like peptide 1 and glucagon in human plasma
por: Wewer Albrechtsen, Nicolai J, et al.
Publicado: (2015)

New evidences for C-reactive protein (CRP) deposits in the arterial intima as a cardiovascular risk factor
por: Montecucco, Fabrizio, et al.
Publicado: (2008)

Glucagon-Like Peptide-1 Receptor Agonist and Glucagon Increase Glucose-Stimulated Insulin Secretion in Beta Cells via Distinct Adenylyl Cyclases
por: Lee, Young-Sun, et al.
Publicado: (2018)

Glucagon-like peptide 1 (GLP-1)
por: Müller, T.D., et al.
Publicado: (2019)

Update on the Pathophysiological Activities of the Cardiac Molecule Cardiotrophin-1 in Obesity
por: Asrih, Mohamed, et al.
Publicado: (2013)

Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration
por: Ammann, Markus, et al.
Publicado: (2023)

Glucagon-like peptide-1 (GLP-1) protects vascular endothelial cells against advanced glycation end products (AGEs) – induced apoptosis
por: Zhan, Yi, et al.
Publicado: (2012)

Glycation affects fibril formation of Aβ peptides
por: Emendato, Alessandro, et al.
Publicado: (2018)

Electrical activity-triggered glucagon-like peptide-1 secretion from primary murine L-cells
por: Rogers, G J, et al.
Publicado: (2011)

Regulation of intestinal lipid and lipoprotein metabolism by the proglucagon-derived peptides glucagon like peptide 1 and glucagon like peptide 2
por: Mulvihill, Erin E.
Publicado: (2018)

Glucagon-Like Peptide-1 and Diabetes
por: Monami, Matteo
Publicado: (2011)

The Immune Response Is Involved in Atherosclerotic Plaque Calcification: Could the RANKL/RANK/OPG System Be a Marker of Plaque Instability?
por: Montecucco, Fabrizio, et al.
Publicado: (2007)

Insulin Resistance: A Proinflammatory State Mediated by Lipid-Induced Signaling Dysfunction and Involved in Atherosclerotic Plaque Instability
por: Montecucco, Fabrizio, et al.
Publicado: (2008)

The Renin-Angiotensin System Modulates Inflammatory Processes in Atherosclerosis: Evidence from Basic Research and Clinical Studies
por: Montecucco, Fabrizio, et al.
Publicado: (2009)

Role of Matrix Metalloproteinase-8 in Atherosclerosis
por: Lenglet, Sébastien, et al.
Publicado: (2013)

Inflammation Is a Key Pathophysiological Feature of Metabolic Syndrome
por: Montecucco, Fabrizio, et al.
Publicado: (2013)

Crystal Structure of Glucagon-like Peptide-1 in Complex with the Extracellular Domain of the Glucagon-like Peptide-1 Receptor
por: Underwood, Christina Rye, et al.
Publicado: (2010)

Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes
por: Lee, Seungah, et al.
Publicado: (2017)

Glucagon-like peptide 1 and Glucagon-like peptide 2 in relation to osteoporosis in non-diabetic postmenopausal women
por: Montes Castillo, María Cristina, et al.
Publicado: (2019)

Glucagon-Like Peptide-1: A Focus on Neurodegenerative Diseases
por: Grieco, Maddalena, et al.
Publicado: (2019)

Glucagon Like Peptide-1 Promotes Adipocyte Differentiation via the Wnt4 Mediated Sequestering of Beta-Catenin
por: Liu, Rui, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_g37kj6m4kming6n6onhta1r98m